An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS？ hydromorphone in patients with chronic cancer pain.docVIP

BMC Palliative Care BioMedCentral Research article Open Access An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS? hydromorphone in patients with chronic cancer pain Magdi Hanna1,2, Alberto Tuca3 and John Thipphawong*4 Address: 1Director of Pain Research Unit, Kings College Hospital, Kings College London, UK, 2Analgesics Pain Research, 62 Park Rd, Beckenham, Kent, UK, 3Medical Coordinator, Hospital Support Team of Palliative Care, Hospital Duran i Reynals, Instituto Catalán de Oncología, Av. Gran Vía de LHospitalet 199-203, LHospitalet, Barcel